TRANSMURAL SYSTEMS
We are passionate about understanding the impact our products have on our patients.
While safety and efficacy are core to everything we do, we regard disruption as an opportunity rather than a major threat. Our confidence in what we design and develop comes from our collective decades of percutaneous experience in the structural heart arena, our development framework, and our strategic partnerships. We have a technology mix that is both complementary and innovative.
Our Profile
Transmural Systems, established in 2013, stands as a private clinical stage medical device company located in Andover, Massachusetts. The Company has a platform of percutaneous structural heart therapies bringing years of combined implant medical device design, development, quality systems, manufacturing and commercialization experience. The Transmural Systems team successfully advanced two of its products (Cerclage Mitral Annuloplasty and Transcaval Closure Device) from early-stage concept to FDA investigational device exemption (IDE) approval, and is successfully executing early feasibility studies.
Clinical stage medical device company
Advanced R&D and manufacturing
facility + Class 7 clean room